These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer.
    Author: Park BK, Kim B, Kim CK, Lee HM, Kwon GY.
    Journal: J Comput Assist Tomogr; 2007; 31(4):534-8. PubMed ID: 17882027.
    Abstract:
    OBJECTIVE: To retrospectively evaluate local staging accuracy for prostate cancer at 3.0-T magnetic resonance imaging (MRI) by comparing with that at 1.5-T MRI. METHODS: Two groups, each consisting of 54 patients, were included by matching for age, prostate specific antigen, and Gleason score. Before radical prostatectomy, 1 group underwent 3.0-T MRI using a phased-array coil, and the other 1.5-T MRI using an endorectal coil. T2-weighted MR images at 3.0 and 1.5 T were analyzed in consensus by 2 radiologists, and their staging accuracy was compared with histology. Artifact and overall image quality were compared at both 3.0 and 1.5 T. RESULTS: Accuracy for T3 stage at 3.0 and 1.5 T were 72% (39/54) and 70% (38/54), respectively (P > 0.05). The 3.0-T MRI had a lower incidence of MR artifacts than the 1.5-T MRI (P < 0.05). However, overall imaging quality at both 3.0 and 1.5 T had no significant difference (P > 0.05). CONCLUSIONS: The 3.0-T phased-array MRI is equivalent to the 1.5-T endorectal MRI in evaluating local staging accuracy for prostate cancer without significant loss of imaging quality.
    [Abstract] [Full Text] [Related] [New Search]